Latest stories on ZBIO
Zenas BioPharma, Inc. (ZBIO) R&D Event: Obexelimab in SLE and ZB021 Development Transcript
Seeking Alpha56 · neutralproduct/pr
Morgan Stanley initiates Zenas Biopharma stock coverage with Equalweight rating
Investing.com Analyst Ratings48 · neutralanalyst
Zenas BioPharma highlights new-hire equity incentives with 74,900 RSUs tied to four-year retention
October 19, 2026
MarketChameleon52 · neutralgeneral
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Insider52 · neutralgeneral
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
StockTitan52 · neutralgeneral
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire52 · neutralgeneral
H.C. Wainwright reiterates Zenas Biopharma stock rating at buy
Investing.com Analyst Ratings58 · neutralanalyst
Zenas BioPharma, Inc. (ZBIO) files 8-K
SEC 8-K50 · neutralgeneral
Zenas BioPharma presents new obexelimab data
The Fly58 · neutralproduct/pr
Zenas BioPharma Announces the Presentation of New Obexelimab Data in IgG4-Related Disease at the 6th International Symposium on IgG4-Related Disease
Business Insider64 · neutralproduct/pr
Zenas BioPharma to Host Virtual R&D Event
Business Insider56 · neutralproduct/pr
Zenas BioPharma: Obexelimab Is Being Graded On The Wrong Curve
Seeking Alpha63 · neutralproduct/pr
Zenas BioPharma price target raised to $48 from $41 at Citi
The Fly61 · neutralanalyst
H.C. Wainwright reiterates Zenas Biopharma stock rating ahead of PDUFA
Investing.com Analyst Ratings56 · neutralanalyst
Zenas BioPharma, Inc. (ZBIO) Discusses Obexelimab Prelaunch Strategy and Commercial Opportunity in IgG4-Related Disease Transcript
Seeking Alpha56 · neutralproduct/pr
Can Zenas BioPharma’s (ZBIO) Clinical Pipeline Justify Its Heavy Cash Burn?
Yahoo Top48 · neutralgeneral
Zenas BioPharma spotlights hiring momentum with 152,600-share inducement equity grants
September 21, 2026
MarketChameleon50 · neutralgeneral
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
StockTitan50 · neutralgeneral
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Insider50 · neutralgeneral
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire50 · neutralgeneral
Zenas BioPharma, Inc. (ZBIO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha56 · neutralgeneral